Engaging Latina breast cancer survivors in research: building a social network research registry
Alejandra Hurtado‐de‐Mendoza(Georgetown University), Vanessa B. Sheppard(Virginia Commonwealth University), Paola Rodriguez-de-Liebana(Georgetown University Medical Center), Sara Gómez Trillos(Georgetown University Medical Center), Nicole C. Fernández(Georgetown University), Aileen I. Fernandez(Yale University), Florencia González(Howard University), Kristi D. Graves(Georgetown University), Adriana Serrano(Georgetown University), Claudia Campos(Nueva Vida), Qi Zhu(Georgetown University), Valeria Massarelli(Georgetown University Medical Center)
Cited by 9
Related Papers
Examination of Low ERBB2 Protein Expression in Breast Cancer Tissue
|JAMA Oncology|2022|347
Deep learning trained on hematoxylin and eosin tumor region of Interest predicts HER2 status and trastuzumab treatment response in HER2+ breast cancer
|Modern Pathology|2021|166
Quantitative measurement of HER2 expression to subclassify ERBB2 unamplified breast cancer
|Laboratory Investigation|2022|141
Multi-institutional Assessment of Pathologist Scoring HER2 Immunohistochemistry
|Modern Pathology|2023|98
Discovery of Biomarkers of Resistance to Immune Checkpoint Blockade in NSCLC Using High-Plex Digital Spatial Profiling
|Journal of Thoracic Oncology|2022|40